These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18722189)

  • 1. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
    Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
    Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
    Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
    J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of post-myocardial infarction patients with left ventricular systolic dysfunction.
    Gheorghiade M; Fonarow GC
    Am J Med; 2007 Feb; 120(2):109-20. PubMed ID: 17275447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure: the challenge of selecting patients for implantable cardioverter defibrillator therapy.
    Chandrasekaran B; Cowburn PJ
    Expert Rev Med Devices; 2010 Jul; 7(4):461-7. PubMed ID: 20583883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the management of patients after myocardial infarction, from admission to discharge.
    Amin A
    Clin Ther; 2006 Oct; 28(10):1509-39. PubMed ID: 17157110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How many leads are needed for an ICD?].
    Schaumann A; Gödde M; Tönnis T
    Herz; 2005 Nov; 30(7):591-5. PubMed ID: 16333583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction.
    Flaherty JD; Davidson CJ; Faxon DP
    Am J Cardiol; 2008 Sep; 102(5A):38G-41G. PubMed ID: 18722190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices.
    Naccarelli GV
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I51-7. PubMed ID: 16450813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RF ablation in a patient with recurrent post-infarction ventricular tachycardia requiring multiple cardioverter-defibrillator interventions].
    Kuśnierz J; Szumowski L; Pastwa L; Bardyszewski A; Lech B; Gil R; Walczak F
    Kardiol Pol; 2005 Nov; 63(5):563-8. PubMed ID: 16362864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
    Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
    Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.